|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen MF, Chen PT, Lu MS, Lee CP and Chen
WC: Survival benefit of surgery to patients with esophageal
squamous cell carcinoma. Sci Rep. 7:461392017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Q, Cai XW, Wu B, Zhu ZF, Chen HQ and
Fu XL: Patterns of failure after radical surgery among patients
with thoracic esophageal squamous cell carcinoma: Implications for
the clinical target volume design of postoperative radiotherapy.
PLoS One. 9:e972252014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsu PK, Chen HS, Huang CS, Liu CC, Hsieh
CC, Hsu HS, Wu YC and Wu SC: Patterns of recurrence after
oesophagectomy and postoperative chemoradiotherapy versus surgery
alone for oesophageal squamous cell carcinoma. Br J Surg.
104:90–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Markar SR, Noordman BJ, Mackenzie H,
Findlay JM, Boshier PR, Ni M, Steyerberg EW, van der Gaast A,
Hulshof MCCM, Maynard N, et al: Multimodality treatment for
esophageal adenocarcinoma: Multi-center propensity-score matched
study. Ann Oncol. 28:519–527. 2017.PubMed/NCBI
|
|
6
|
Kumaran D, John S, Isiah R and Das S:
Management of locally advanced carcinoma oesophagus with
radiation/chemoradiation: Single institute experience. J
Gastrointest Cancer. 47:313–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Y, Wang H, Luo G, Zhang Y, Wang L
and Li K: A systematic review and network meta-analysis of
neoadjuvant therapy combined with surgery for patients with
resectable esophageal squamous cell carcinoma. Int J Surg.
38:41–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
National Comprehensive Cancer Network, .
Esophageal Cancer Clinical Practice Guidelines in Oncology.
http://www.nccn.org/professionals/physician_gls/f_guidelines.aspJuly
1–2016
|
|
9
|
Thallinger CM, Kiesewetter B, Raderer M
and Hejna M: Pre- and postoperative treatment modalities for
esophageal squamous cell carcinoma. Anticancer Res. 32:4609–4627.
2012.PubMed/NCBI
|
|
10
|
Zhu Y, Li M, Kong L and Yu J:
Postoperative radiation in esophageal squamous cell carcinoma and
target volume delineation. Onco Targets Ther. 9:4187–4196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ku GY and Ilson DH: Adjuvant
(postoperative) therapy for esophageal cancer. Thorac Surg Clin.
23:525–533. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishimaki T, Tanaka O, Suzuki T, Aizawa K,
Hatakeyama K and Muto T: Patterns of lymphatic spread in thoracic
esophageal. Cancer. 74:4–11. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Herbella FA, Del Grande JC and Colleoni R;
Japanese Society for Disease of the Esophagus, : Anatomical
analysis of the mediastinal lymph nodes of normal Brazilian
subjects according to the classification of the Japanese Society
for Diseases of the Esophagus. Surg Today. 33:249–253. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gotohda N, Nishimura M, Yoshida J, Nagai K
and Tanaka N: The pattern of lymphatic metastases in squamous cell
carcinoma of the esophagus. Hepatogastroenterology. 52:105–107.
2005.PubMed/NCBI
|
|
15
|
Sgourakis G, Gockel I, Lyros O, Hansen T,
Mildenberger P and Lang H: Detection of lymph node metastases in
esophageal cancer. Expert Rev Anticancer Ther. 11:601–612. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ténière P, Hay JM, Fingerhut A and Fagniez
PL: Postoperative radiation therapy does not increase survival
after curative resection for squamous cell carcinoma of the middle
and lower esophagus as shown by a multicenter controlled trial.
French University Association for Surgical Research. Surg Gynecol
Obstet. 173:123–130. 1991.PubMed/NCBI
|
|
17
|
Rice TW, Adelstein DJ, Chidel MA, Rybicki
LA, DeCamp MM, Murthy SC and Blackstone EH: Benefit of
postoperative adjuvant chemoradiotherapy in locoregionally advanced
esophageal carcinoma. J Thorac Cardiovasc Surg. 126:1590–1596.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu E, Tai P, Younus J, Malthaner R, Truong
P, Stitt L, Rodrigues G, Ash R, Dar R, Yaremko B, et al:
Postoperative extended-volume external-beam radiation therapy in
high-risk esophageal cancer patients: A prospective experience.
Curr Oncol. 16:48–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiao XY, Wang W, Zhou ZG, Gao XS and Chang
JY: Comparison of efficacy of regional and extensive clinical
target volumes in postoperative radiotherapy for esophageal
squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 70:396–402.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang W, Liu X, Xiao Z, Wang L, Zhang H,
Chen D, Zhou Z, Feng Q, Hui Z, Liang J, et al: Efficacy of
intensity-modulated radiotherapy for resected thoracic esophageal
squamous cell carcinoma. Thorac Cancer. 6:597–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu X, Xie HY, Zhou D, Huang RH, Bai YR,
Yuan J and Ye M: Comparison and prognostic analysis of adjuvant
radiotherapy versus salvage radiotherapy for treatment of radically
resected locally advanced esophageal squamous cell carcinoma.
Biomed Res Int. 2016:85486942016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakagawa S, Kanda T, Kosugi S, Ohashi M,
Suzuki T and Hatakeyama K: Recurrence pattern of squamous cell
carcinoma of the thoracic esophagus after extended radical
esophagectomy with three-field lymphadenectomy. J Am Coll Surg.
198:205–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ninomiya I, Okamoto K, Tsukada T,
Kinoshita J, Oyama K, Fushida S, Osugi H and Ohta T: Recurrence
patterns and risk factors following thoracoscopic esophagectomy
with radical lymph node dissection for thoracic esophageal squamous
cell carcinoma. Mol Clin Oncol. 4:278–284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu SG, Dai MM, He ZY, Sun JY, Lin HX, Lin
H and Li Q: Patterns of regional lymph noed recurrence after
radical surgery for thoracic esophageal squamous cell carcinoma.
Ann Thorac Surg. 101:551–557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugiyama M, Morita M, Yoshida R, Ando K,
Egashira A, Takefumi O, Saeki H, Oki E, Kakeji Y, Sakaguchi Y and
Maehara Y: Patterns and time of recurrence after complete resection
of esophageal cancer. Surg Today. 42:752–758. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Japanese Esophageal Society, . Japanese
Classification of Esophageal Cancer, 11th Edition: Part I.
Esophagus. 14:1–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumors. 7th. Wiley-Blackwell;
Oxford: 2010
|
|
28
|
Rusch VW, Asamura H, Watanabe H, Giroux
DJ, Rami-Porta R and Goldstraw P; Members of IASLC Staging
Committee, : The IASLC lung cancer staging project: A proposal for
a new international lymph node map in the forthcoming seventh
edition of the TNM classification for lung cancer. J Thorac Oncol.
4:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ela Bella AJ, Zhang YR, Fan W, Luo KJ,
Rong TH, Lin P, Yang H and Fu JH: Maximum standardized uptake value
on PET/CT in preoperative assessment of lymph node metastasis from
thoracic esophageal squamous cell carcinoma. Chin J Cancer.
33:211–217. 2014.PubMed/NCBI
|
|
30
|
Wong AT, Shao M, Rineer J, Lee A, Schwartz
D and Schreiber D: The impact of adjuvant postoperative radiation
therapy and chemotherapy on survival after esophagectomy for
esophageal carcinoma. Ann Surg. 265:1146–1151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prenzel KL, Hölscher AH, Drebber U,
Agavonova M, Gutschow CA and Bollschweiler E: Prognostic impact of
nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol.
38:314–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mumtaz WR, Hegde V and Yadav N:
Micrometastasis detection using special stains in nodal tissues of
oral squamous cell carcinoma-a histochemical study. J Clin Diagn
Res. 10:ZC23–ZC26. 2016.PubMed/NCBI
|
|
33
|
Zhou Z, Qutaish M, Han Z, Schur RM, Liu Y,
Wilson DL and Lu ZR: MRI detection of breast cancer micrometastases
with a fibronectin-targeting contrast agent. Nat Commun.
6:79842015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cai WJ and Xin PL: Pattern of relapse in
surgical treated patients with thoracic esophageal squamous cell
carcinoma and its possible impact on target delineation for
postoperative radiotherapy. Radiother Oncol. 96:104–107. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Riquet M, Saab M, Le Pimpec Barthes F and
Hidden G: Lymphatic drainage of the esophagus in the adult. Surg
Radiol Anat. 15:209–211. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang WC, Wang QF, Xiao ZF, Yang LH and
Liu XY: Patterns of failure after complete resection of thoracic
esophageal squamous cell carcinoma: Implications for postoperative
radiation therapy volumes. Chin J Radiat Oncol Oncol Radiat Oncol.
21:38–41. 2012.(In Chinese).
|
|
37
|
Chen J, Liu S, Pan J, Zheng X, Zhu K, Zhu
J, Xiao J and Ying M: The pattern and prevalence of lymphatic
spread in thoracic oesophageal squamous cell carcinoma. Eur J
Cardiothorac Surg. 36:480–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oppedijk V, van der Gaast A, van Lanschot
JJ, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema
JC, Rütten H, Spruit PH, et al: Patterns of recurrence after
surgery alone versus preoperative chemoradiotherapy and surgery in
the CROSS trials. J Clin Oncol. 32:385–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Moon S, Kim H, Chie E, Kim J and Park C:
Positive impact of radiation dose on disease free survival and
locoregional control in postoperative radiotherapy for squamous
cell carcinoma of esophagus. Dis Esophagus. 22:298–304. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li CL, Zhang FL, Wang YD, Han C, Sun GG,
Liu Q, Cheng YJ, Jing SW and Yang CR: Characteristics of recurrence
after radical esophagectomy with two-field lymph node dissection
for thoracic esophageal cancer. Oncol Lett. 5:355–359. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim KH, Chang JS, Cha JH, Lee IJ, Kim DJ,
Cho BC, Park KR and Lee CG: Optimal adjuvant treatment for
curatively resected thoracic esophageal squamous cell carcinoma: A
radiotherapy perspective. Cancer Res Treat. 49:168–177. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yamashita K, Watanabe M, Mine S, Kurogochi
T, Okamura A, Hayami M and Imamura Y: Patterns and outcomes of
recurrent esophageal cancer after curative esophagectomy. World J
Surg. 41:2337–2344. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang X, Luo Y, Li M, Yan H, Sun M and Fan
T: Recurrence pattern of squamous cell carcinoma in the midthoracic
esophagus: Implications for the clinical target volume design of
postoperative radiotherapy. Onco Targets Ther. 9:6021–6027. 2016.
View Article : Google Scholar : PubMed/NCBI
|
